drugset / Trial / NCT06045364
Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation
RandomizedParallel-groupTriple-blindTreatment
Summary
This study aims to determine the role of Glycopyrrolate in preventing postoperative nausea and vomiting of ERCP.
Timeline
- Start
- 2023-10-01
- Primary completion
- 2024-07-20
- Completion
- 2024-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Anisodamine | Traditional medicine (herbal / TCM) | 10 mg | Intramuscular |
| Subject | Glycopyrrolate | Small molecule | 0.2 mg | Intravenous |
Indications
No indication recorded.